2024 Thematic Discussions on the Implementation of All International Drug Policy Commitments, Following-up to the 2019 Ministerial Declaration Chair: Good Morning. Secretariat: (organizational matters + scheduling 101) Moderator/intro: Mr. Justice Tettey, Chief, Drugs, Laboratory and Scientific Services Branch, UNODC: Good morning, dear colleagues. Thank you for this opportunity to address the question you posed about …
2024 Thematic Discussions on the Implementation of All International Drug Policy Commitments, Following-up to the 2019 Ministerial Declaration Chair: Hello, good afternoon, everyone. Welcome back. Let’s begin the afternoon session. Introductory remarks: Mr. Michael Osman, Social Affairs Officer, Border Management Branch, UNODC: I’ll provide a brief overview to leave more time for our interactive discussions …
2024 Thematic Discussions on the Implementation of All International Drug Policy Commitments, Following-up to the 2019 Ministerial Declaration Chair: Welcome back. Ms. Asma Fakhri, UNODC, on behalf of Mr. Justice TETTEY, Chief, Drugs, Laboratory and Scientific Services Branch, UNODC (Moderator): Thank you all for gathering to address the growing challenges posed by synthetic opioids and the non-medical …
UN Web TV recording ;Bangladesh/Chair: Discuss the work done around the globe to implement drug control commitments – identify progress, identify challenges. This will consist of a panel of interventions followed by interactive discussions. Mexico/Co-Chair: Delegations wishing to take the floor can raise their panels to nominate themselves. Please bear with me if I call …
Chair: I am grateful for your cooperation earlier this year. We had previously discussed the Resolution, outlining the review process, and collectively decided to convene before he regular committee session. The high-level segment is scheduled for March 14th and 15th, dedicated to assessing the implementation of international drug policy commitments. During this segment, we aim …
Chair: Good Morning. Yesterday we had a fruitful discussion on the issues of the consequences and risk associated with non medical use of drugs. Today we will be discussing the low availability of nationally controlled substances for medical and scientific purposes, including for the relief of pain and palliative care. Before we start a discussion, …